| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | — |
| Cost of Revenue | $1.6M | — |
| Gross Profit | -$342K | — |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $1.7M | +8.6% |
| Operating Income | -$2.0M | -495.5% |
| Pre-tax Income | -$2.0M | -496.6% |
| Income Tax | $250K | — |
| Net Income | -$2.2M | -571.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $187K | — |
| Current Assets | $198K | +692.0% |
| Total Assets | $215K | +761.4% |
| Current Liabilities | $1.9M | +258.5% |
| Total Liabilities | $1.9M | +258.6% |
| Stockholders' Equity | -$1.7M | -234.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.7M | -495.6% |
| Capital Expenditures | $352 | +45.5% |
| Investing Cash Flow | -$352 | — |
| Financing Cash Flow | $440K | +53.4% |
| Free Cash Flow | -$1.7M | -495.2% |